INDIA |NSE |INR
Shares Outstanding | 52.90M | Beta | 0.68 |
---|---|---|---|
Public Float | 13.79M | P/E Ratio | 22.64 |
% Short of Float | - | Dividend (Yield) | 15.00 (0.03%) |
Held by Insiders | 71.18% | Ex-Dividend Date | Jun 17, 2021 |
Held by Institutions | 13.82% | IPO Date | - |
Mar 21 | Mar 20 | Mar 19 | |
---|---|---|---|
Revenue | INR4.95B | INR4.33B | INR4.03B |
EBITDA | INR1.84B | INR1.74B | INR1.65B |
Net Income | INR1.13B | INR884.10M | INR851.40M |
Total Assets | INR5.46B | INR4.69B | INR4.75B |
Total Cash | INR132.00M | INR87.00M | INR49.10M |
Total Debt | INR84.90M | INR124.40M | INR25.00M |
Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|
Revenue | INR1.17B | INR1.76B | INR1.65B |
EBITDA | INR380.00M | INR1.04B | INR814.30M |
Net Income | INR215.00M | INR777.30M | INR555.70M |
Total Assets | INR5.96B | INR5.83B | INR5.41B |
Total Cash | INR75.00M | INR61.10M | INR448.80M |
Total Debt | INR | INR227.60M | INR239.80M |
Year | Open | Close | Change |
---|---|---|---|
2021 | INR1112.00 | INR1140.95 | 2.60% |
2021 | INR917.55 | INR1112.00 | 21.19% |
2020 | INR545.15 | INR917.55 | 68.31% |
Date | Open | High | Low | Close | Change | Volume |
---|---|---|---|---|---|---|
Jun 15, 2022 | INR661.40 | INR669.80 | INR660.00 | INR664.25 | 4.84% | 29.21K |
Jun 22, 2022 | INR620.10 | INR641.95 | INR620.10 | INR633.60 | 0.63% | 34.72K |
Jun 24, 2022 | INR631.80 | INR637.95 | INR624.65 | INR629.65 | -6.25% | 28.17K |
Thyrocare technologies trades on the NSE stock market in India under the ticker symbol "THYROCARE". Thyrocare technologies’s stock symbol can also be displayed as "NSE:THYROCARE".
Thyrocare technologies (NSE:THYROCARE) is owned by 13.82% institutional shareholders and by 71.18% insiders. The rest is owned by the public.
Explore More Details on Thyrocare technologies's “Ownership” Section
Thyrocare technologies's key executive team includes the following managers:
Thyrocare technologies (NSE:THYROCARE) is classified under the "Healthcare" sector and under the "Diagnostics & Research" industry.
Currently the number of employees working for Thyrocare technologies is 1,582.
Thyrocare technologies (NSE:THYROCARE) is headquartered in India.
Thyrocare technologies’s mailing address is D/37-3, TTC Industrial Area, Navi Mumbai, India, 400703.
The company’s phone number is 91 22 4125 2525.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.